Compare DNTH & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNTH | NXE |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.9B |
| IPO Year | 2018 | 2017 |
| Metric | DNTH | NXE |
|---|---|---|
| Price | $84.41 | $6.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 16 |
| Target Price | ★ $139.25 | $15.35 |
| AVG Volume (30 Days) | 723.8K | ★ 5.9M |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,036,000.00 | N/A |
| Revenue This Year | $22.80 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $35.84 | $6.85 |
| 52 Week High | $117.88 | $13.96 |
| Indicator | DNTH | NXE |
|---|---|---|
| Relative Strength Index (RSI) | 44.01 | 28.49 |
| Support Level | $79.54 | N/A |
| Resistance Level | $91.36 | $9.79 |
| Average True Range (ATR) | 4.84 | 0.39 |
| MACD | -0.08 | -0.13 |
| Stochastic Oscillator | 19.24 | 1.47 |
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
NexGen Energy Ltd is an exploration and development stage entity engaged in the acquisition, exploration, evaluation, and development of uranium properties in Canada. The Rook I Project is a development-stage uranium project in Canada. The Company also holds a prospective portfolio of uranium exploration projects in the historic eastern Athabasca Basin.